Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function

European Journal of Heart Failure

Volumn 9, Issue 9, 2007, Pages 865-871

  Balmain, Sean ^a   Padmanabhan, Neal ^a   Ferrell, William R ^b   Morton, John J ^a   McMurray, John J V ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Arteries; Diastole; Endothelium; Heart failure; Veins

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL STIMULATING AGENT; THIAZIDE DIURETIC AGENT;

AGED; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART RATE; HUMAN; HYPERTENSION; IMAGING SYSTEM; IONTOPHORESIS; MALE; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; TONOMETRY; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

AGED; AGED, 80 AND OVER; ARTERIES; COMPLIANCE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; SYSTOLE; VASCULAR CAPACITANCE; VEINS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 34548229941     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.06.003     Document Type: Article

References (51)

1. Vasan R.S., Benjamin E.J., and Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 26 7 (1995) 1565-1574
2. Hogg K., Swedberg K., and McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43 3 (2004) 317-327
3. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., and Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 3 (2006) 251-259
4. Bhatia R.S., Tu J.V., Lee D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 3 (2006) 260-269
5. Zile M.R., Baicu C.F., and Gaasch W.H. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350 19 (2004) 1953-1959
6. Vasan R.S., and Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 101 17 (2000) 2118-2121
7. Burkhoff D., Maurer M.S., and Packer M. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function?. Circulation 107 5 (2003) 656-658
8. Hundley W.G., Kitzman D.W., Morgan T.M., et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 38 3 (2001) 796-802
9. Kawaguchi M., Hay I., Fetics B., and Kass D.A. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 107 5 (2003) 714-720
10. Kass D.A. Is heart failure with decent systole due to bad diastole?. J Card Fail 11 3 (2005) 188-190
11. Steendijk P. Heart failure with preserved ejection fraction. Diastolic dysfunction, subtle systolic dysfunction, systolic-ventricular and arterial stiffening, or misdiagnosis?. Cardiovasc Res 64 1 (2004) 9-11
12. Redfield M.M., Jacobsen S.J., Borlaug B.A., Rodeheffer R.J., and Kass D.A. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 112 15 (2005) 2254-2262
13. Kass D.A. Ventricular arterial stiffening. Integrating the pathophysiology. Hypertension 46 1 (2005) 185-193
14. Zieman S.J., Melenovsky V., and Kass D.A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 25 5 (2005) 932-943
15. Nightingale A.K., Blackman D.J., Ellis G.R., et al. Preservation of venous endothelial function in the forearm venous capacitance bed of patients with chronic heart failure despite arterial endothelial dysfunction. J Am Coll Cardiol 37 4 (2001) 1062-1068
16. Meyer B., Mortl D., Strecker K., et al. Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide. J Am Coll Cardiol 46 6 (2005) 1011-1018
17. Katz S.D., Biasucci L., Sabba C., et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 19 5 (1992) 918-925
18. Bank A.J., Rector T.S., Tschumperlin L.K., Kraemer M.D., Letourneau J.G., and Kubo S.H. Endothelium-dependent vasodilation of peripheral conduit arteries in patients with heart failure. J Card Fail 1 1 (1994) 35-43
19. Kubo S.H., Rector T.S., Bank A.J., Williams R.E., and Heifetz S.M. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84 4 (1991) 1589-1596
20. Just H. Peripheral adaptations in congestive heart failure: a review. Am J Med 90 5B (1991) 23S-26S
21. Struthers A.D. Impact of aldosterone on vascular pathophysiology. Congest Heart Fail 8 1 (2002) 18-22
22. Tousoulis D., Charakida M., and Stefanadis C. Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure. Int J Cardiol 100 3 (2005) 347-353
23. Elesber A.A., and Redfield M.M. Approach to patients with heart failure and normal ejection fraction. Mayo Clin Proc 76 10 (2001) 1047-1052
24. Angeja B.G., and Grossman W. Evaluation and management of diastolic heart failure. Circulation 107 5 (2003) 659-663
25. Welsch M.A., Alomari M., Parish T.R., Wood R.H., and Kalb D. Influence of venous function on exercise tolerance in chronic heart failure. J Cardiopulm Rehabil 22 5 (2002) 321-326
26. Remes J., Miettinen H., Reunanen A., and Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 12 3 (1991) 315-321
27. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 5 (1989) 358-367
28. McLeod A.L., Uren N.G., Wilkinson I.B., et al. Non-invasive measures of pulse wave velocity correlate with coronary arterial plaque load in humans. J Hypertens 22 2 (2004) 363-368
29. Ferrier K.E., Waddell T.K., Gatzka C.D., Cameron J.D., Dart A.M., and Kingwell B.A. Aerobic exercise training does not modify large-artery compliance in isolated systolic hypertension. Hypertension 38 2 (2001) 222-226
30. Jhund P.S., Davie A.P., and McMurray J.J. Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. J Am Coll Cardiol 37 5 (2001) 1234-1238
31. Gill J.M., Al Mamari A., Ferrell W.R., et al. Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. J Am Coll Cardiol 44 12 (2004) 2375-2382
32. Ramsay J.E., Ferrell W.R., Crawford L., Wallace A.M., Greer I.A., and Sattar N. Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauterine growth restriction: relevance of adiposity. J Hypertens 22 11 (2004) 2177-2183
33. Ramsay J.E., Ferrell W.R., Greer I.A., and Sattar N. Factors critical to iontophoretic assessment of vascular reactivity: implications for clinical studies of endothelial dysfunction. J Cardiovasc Pharmacol 39 1 (2002) 9-17
34. Bramwell J.C., and Hill A.V. The velocity of the pulse wave in man. Proc R Soc Lond B Biol Sci 93 (1922) 298-306
35. Dart A.M., and Kingwell B.A. Pulse pressure-a review of mechanisms and clinical relevance. J Am Coll Cardiol 37 4 (2001) 975-984
36. Smulyan H., Asmar R.G., Rudnicki A., London G.M., and Safar M.E. Comparative effects of aging in men and women on the properties of the arterial tree. J Am Coll Cardiol 37 5 (2001) 1374-1380
37. Dart A.M., and Kingwell B.A. Pulse pressure - a review of mechanisms and clinical relevance. J Am Coll Cardiol 37 4 (2001) 975-984
38. Katz S.D., Biasucci L., Sabba C., et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 19 5 (1992) 918-925
39. Maguire S.M., Nugent A.G., McGurk C., Johnston G.D., and Nicholls D.P. Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent. Heart 80 2 (1998) 141-145
40. Negrao C.E., Hamilton M.A., Fonarow G.C., Hage A., Moriguchi J.D., and Middlekauff H.R. Impaired endothelium-mediated vasodilation is not the principal cause of vasoconstriction in heart failure. Am J Physiol Heart Circ Physiol 278 1 (2000) H168-H174
41. Andersson S.E., Edvinsson M.L., and Edvinsson L. Cutaneous vascular reactivity is reduced in aging and in heart failure: association with inflammation. Clin Sci (Lond) 105 6 (2003) 699-707
42. Morgan D.R., Dixon L.J., Hanratty C.G., et al. Impaired endothelium-dependent and -independent vasodilation in elderly patients with chronic heart failure. Eur J Heart Fail 6 7 (2004) 901-908
43. Bank A.J., Rector T.S., Tschumperlin L.K., Kraemer M.D., Letourneau J.G., and Kubo S.H. Endothelium-dependent vasodilation of peripheral conduit arteries in patients with heart failure. J Card Fail 1 1 (1994) 35-43
44. Drexler H., Hayoz D., Munzel T., et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 69 19 (1992) 1596-1601
45. Kubo S.H., Rector T.S., Bank A.J., Williams R.E., and Heifetz S.M. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84 4 (1991) 1589-1596
46. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 10 (2000) 840-844
47. Heymes C., Bendall J.K., Ratajczak P., et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41 12 (2003) 2164-2171
48. Lopez F.A., and Casado S. Heart failure, redox alterations, and endothelial dysfunction. Hypertension 38 6 (2001) 1400-1405
49. Schmitt M., Blackman D.J., Middleton G.W., Cockcroft J.R., and Frenneaux M.P. Assessment of venous capacitance. Radionuclide plethysmography: methodology and research applications. Br J Clin Pharmacol 54 6 (2002) 565-576
50. Schmitt M., Gunaruwan P., Payne N., et al. Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure. Arterioscler Thromb Vasc Biol 24 5 (2004) 911-917
51. Nightingale A.K., Blackman D.J., Ellis G.R., et al. Preservation of venous endothelial function in the forearm venous capacitance bed of patients with chronic heart failure despite arterial endothelial dysfunction. J Am Coll Cardiol 37 4 (2001) 1062-1068